BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 17145753)

  • 1. Urokinase receptors are required for alpha 5 beta 1 integrin-mediated signaling in tumor cells.
    Wei Y; Tang CH; Kim Y; Robillard L; Zhang F; Kugler MC; Chapman HA
    J Biol Chem; 2007 Feb; 282(6):3929-39. PubMed ID: 17145753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of alpha5beta1 integrin conformation and function by urokinase receptor binding.
    Wei Y; Czekay RP; Robillard L; Kugler MC; Zhang F; Kim KK; Xiong JP; Humphries MJ; Chapman HA
    J Cell Biol; 2005 Jan; 168(3):501-11. PubMed ID: 15684035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signaling through urokinase and urokinase receptor in lung cancer cells requires interactions with beta1 integrins.
    Tang CH; Hill ML; Brumwell AN; Chapman HA; Wei Y
    J Cell Sci; 2008 Nov; 121(Pt 22):3747-56. PubMed ID: 18940913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The receptor for urokinase-type plasminogen activator regulates fibronectin matrix assembly in human skin fibroblasts.
    Monaghan E; Gueorguiev V; Wilkins-Port C; McKeown-Longo PJ
    J Biol Chem; 2004 Jan; 279(2):1400-7. PubMed ID: 14602715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical role of integrin alpha 5 beta 1 in urokinase (uPA)/urokinase receptor (uPAR, CD87) signaling.
    Tarui T; Andronicos N; Czekay RP; Mazar AP; Bdeir K; Parry GC; Kuo A; Loskutoff DJ; Cines DB; Takada Y
    J Biol Chem; 2003 Aug; 278(32):29863-72. PubMed ID: 12754207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urokinase receptors promote beta1 integrin function through interactions with integrin alpha3beta1.
    Wei Y; Eble JA; Wang Z; Kreidberg JA; Chapman HA
    Mol Biol Cell; 2001 Oct; 12(10):2975-86. PubMed ID: 11598185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urokinase-type plasminogen activator binding to its receptor stimulates tumor cell migration by enhancing integrin-mediated signal transduction.
    Yebra M; Goretzki L; Pfeifer M; Mueller BM
    Exp Cell Res; 1999 Jul; 250(1):231-40. PubMed ID: 10388537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urokinase-type plasminogen activator receptor (uPAR) ligation induces a raft-localized integrin signaling switch that mediates the hypermotile phenotype of fibrotic fibroblasts.
    Grove LM; Southern BD; Jin TH; White KE; Paruchuri S; Harel E; Wei Y; Rahaman SO; Gladson CL; Ding Q; Craik CS; Chapman HA; Olman MA
    J Biol Chem; 2014 May; 289(18):12791-804. PubMed ID: 24644284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urokinase-type plasminogen activator receptors associate with beta1 and beta3 integrins of fibrosarcoma cells: dependence on extracellular matrix components.
    Xue W; Mizukami I; Todd RF; Petty HR
    Cancer Res; 1997 May; 57(9):1682-9. PubMed ID: 9135008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urokinase receptor and fibronectin regulate the ERK(MAPK) to p38(MAPK) activity ratios that determine carcinoma cell proliferation or dormancy in vivo.
    Aguirre-Ghiso JA; Liu D; Mignatti A; Kovalski K; Ossowski L
    Mol Biol Cell; 2001 Apr; 12(4):863-79. PubMed ID: 11294892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling.
    Aguirre Ghiso JA; Kovalski K; Ossowski L
    J Cell Biol; 1999 Oct; 147(1):89-104. PubMed ID: 10508858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A region in urokinase plasminogen receptor domain III controlling a functional association with alpha5beta1 integrin and tumor growth.
    Chaurasia P; Aguirre-Ghiso JA; Liang OD; Gardsvoll H; Ploug M; Ossowski L
    J Biol Chem; 2006 May; 281(21):14852-63. PubMed ID: 16547007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of mouse embryo fibroblast N-acetylglucosaminyltransferase V stimulates alpha5beta1 integrin expression mediated by the protein kinase C signaling pathway.
    Guo HB; Lee I; Bryan BT; Pierce M
    J Biol Chem; 2005 Mar; 280(9):8332-42. PubMed ID: 15615721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of integrins in invasion of endometrial cancer cell lines.
    Prifti S; Zourab Y; Koumouridis A; Bohlmann M; Strowitzki T; Rabe T
    Gynecol Oncol; 2002 Jan; 84(1):12-20. PubMed ID: 11748970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ERK(MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38(SAPK).
    Aguirre-Ghiso JA; Estrada Y; Liu D; Ossowski L
    Cancer Res; 2003 Apr; 63(7):1684-95. PubMed ID: 12670923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urokinase-type plasminogen activator inhibits alpha 4 beta 1 integrin-mediated T lymphocyte adhesion to fibronectin independently of its catalytic activity.
    Olivier P; Bieler G; Müller KM; Hauzenberger D; Rüegg C
    Eur J Immunol; 1999 Oct; 29(10):3196-209. PubMed ID: 10540331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoglin mediates fibronectin/α5β1 integrin and TGF-β pathway crosstalk in endothelial cells.
    Tian H; Mythreye K; Golzio C; Katsanis N; Blobe GC
    EMBO J; 2012 Oct; 31(19):3885-900. PubMed ID: 22940691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aeroallergen Der p 2 promotes motility of human non-small cell lung cancer cells via toll-like receptor-mediated up-regulation of urokinase-type plasminogen activator and integrin/focal adhesion kinase signaling.
    Lin CH; Lin HH; Kuo CY; Kao SH
    Oncotarget; 2017 Feb; 8(7):11316-11328. PubMed ID: 28076322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization of urokinase type plasminogen activator to focal adhesions requires ligation of vitronectin integrin receptors.
    Wilcox-Adelman SA; Wilkins-Port CE; McKeown-Longo PJ
    Cell Adhes Commun; 2000; 7(6):477-90. PubMed ID: 11051458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of fibronectin in the regulation of urokinase production and binding in murine mammary tumor cells.
    Urtreger AJ; Aguirre Ghiso JA; Werbajh SE; Puricelli LI; Muro AF; Bal de Kier Joff E
    Int J Cancer; 1999 Aug; 82(5):748-53. PubMed ID: 10417775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.